More stories

  • in

    Can UBS make the most of finance’s deal of the century?

    “Limited but intensive”. That is how a regulatory filing described, with something approaching wry understatement, the few days of due diligence before ubs announced its deal to rescue Credit Suisse on March 19th. The acquisition was the first ever tie-up between two “global systemically important banks”, a designation introduced after the global financial crisis of 2007-09. Since it was announced, the pace has barely slowed. In April Sergio Ermotti, a Swiss cost-cutter who ran ubs between 2011 and 2020, returned as the firm’s chief executive. The same month Credit Suisse’s results laid bare the brutal run it had suffered. Combined financial statements followed in May. The fine print of an agreement with Swiss authorities to absorb potential losses emerged in June. Scores of Credit Suisse bankers have rushed for the exit.ubs finally got the keys to the building on June 12th. The tie-up is the most watched deal in finance. It creates a giant with $5trn of invested assets and a balance-sheet twice the size of the Swiss economy. The acquisition’s outcome will say much about the future of global banking. Regulators are eyeing proceedings closely on account of the new institution’s size. Bank bosses, meanwhile, are watching the difficult strategic decisions faced by management for lessons applicable to their own firms. UBS shareholders, who did not vote for the deal, have traded a staid investment for something much riskier. Despite absorbing its risk-taking rival, bosses hope that the new ubs will be able to emerge as an enlarged version of the old ubs. European banks were slow to recapitalise after the global financial crisis; their profitability largely reflected ailing domestic economies. Amid this inauspicious crowd, ubs stood out. After being rescued in 2008, the bank focused on wealth management. It won enough wallets to be rewarded with one of the highest price-to-book multiples of any European bank, trading at an average of 1.1 times its book value last year. ubs’s focus on managing money will continue, but the shape and scale of its other banking businesses is still the subject of internal debate. Nobody expects a smooth ride in the years ahead.Since the deal was announced, shares in ubs have risen only a little. Yet the acquisition ought to be a boon, at least eventually. ubs bought Credit Suisse at a bargain: it will report an estimated $35bn of “negative goodwill”, the difference between what it paid and the higher book value of Credit Suisse’s equity. Turning this scale into profit hinges on the mammoth task of integrating the two institutions’ operations. All the usual post-merger headaches—combining it systems, aligning accounting standards, laying off staff and resolving culture clashes—are especially troublesome at a bank, let alone a failed one. Compared with ubs, Credit Suisse was appallingly inefficient: the bank had a higher ratio of costs to income in every one of its businesses. Its collapse was preceded by five consecutive quarters of losses and a stunning evaporation of confidence among clients and counterparties.When ubs unveils its plans and delayed quarterly results at the end of August, investors will scrutinise any outflow of assets managed by the bank. There is little to suggest a large exodus has taken place. Julius Baer, a Swiss outfit that is likely to benefit from any flight, reported only modest inflows at its quarterly results on July 24th. But investors should also focus on two strategic decisions—ones which will ultimately determine the success of the deal. Both require knife-edge calls and present enormous execution challenges.Credit Suisse’s domestic business is the first question mark. Bosses at ubs are debating whether to keep none, some or all of Credit Suisse Schweiz, which was established in 2016 as part of a plan, later shelved, to spin off the business. The Swiss bank was Credit Suisse’s only profitable division during the first quarter of 2023. Last year Schweiz’s equity had a book value of SFr13bn ($14bn). Selling the outfit at a valuation near this figure might be impossible given the speed with which clients fled before March. A shaky balance-sheet would hinder efforts to pick off better bits of the business, since the rump might struggle to support itself as a standalone operation. Taking the SwissAnger over the tie-up is still simmering in Switzerland. The fate of Credit Suisse’s domestic business could emerge as something of a political lightning rod. Shedding Schweiz might stave off demands for higher capital requirements in the future by calming worries about the parent bank’s size. According to data from Switzerland’s central bank, last year ubs and Credit Suisse had combined domestic market shares of 26% in loans and deposits. In less dramatic circumstances, it would have been possible to imagine the deal falling foul of competition watchdogs.Yet whereas gains from second-guessing political currents are uncertain, gains from keeping the business and making cuts are almost guaranteed. Assuming ubs’s shears are sufficiently sharp, and 70% of Credit Suisse Schweiz’s costs can be chopped, separating the whole business would mean forgoing nearly a third of the deal’s total annual cost savings, according to Barclays, a bank. Lay-offs affecting Credit Suisse’s 16,700 employees in Switzerland, such as from shutting retail branches, would draw particular ire from politicians and the public. According to Jefferies, an investment bank, around 60% of UBS and Credit Suisse branches are located within a kilometre of each other.The second question mark concerns Credit Suisse’s investment bank, which accounted for a third of the institution’s costs last year, and will bear the brunt of the cuts. Mr Ermotti is no stranger to felling bankers: the number of people employed in ubs’s investment bank declined from about 17,000 in 2011 to 5,000 in 2019, leaving behind a leaner operation to play second fiddle to the bank’s elite wealth-management division. Credit Suisse failed to accomplish similar manoeuvres of its own. Therefore ubs last year generated nearly five times as much revenue per dollar of value at risk.Winding down these operations will be a slog. Much of Credit Suisse’s investment-banking operations will be shoved into a “non-core” unit, along with some small parts of Credit Suisse’s money-managing businesses. Modern “bad banks” do not contain masses of toxic derivatives, like an older generation did after the global financial crisis. But they are still hard to shutter without incurring significant losses.Protection against losses from selling some of Credit Suisse’s assets is provided by the Swiss government. As part of the acquisition agreement, the authorities committed themselves to absorbing up to SFr9bn of losses, so long as the first SFr5bn are shouldered by ubs. They are unlikely to have to cough up, however, given the relatively small pool of assets covered by the agreement. As a result, ubs could move to end the agreement before it has wound down the portfolio. The guarantee proved reassuring to investors during March’s turmoil. Today it carries a lot of political risk for not all that much financial gain.Moreover, the loss guarantee fails to insure against the greatest danger when it comes to winding down an investment bank: that revenues plummet faster than costs, creating uncomfortable losses. Even excluding the sizeable cost of employees and one-off items, outgoings in Credit Suisse’s investment bank last year amounted to more than 60% of revenue. Many of these costs, such as the technology systems required to run a trading floor, will remain high even as assets are sold off. Consider Credit Suisse’s own wind-down unit, which the bank created as part of its failed restructuring programme. The unit’s assets have fallen by almost half since 2021, to SFr98bn; its costs, at SFr3bn in 2022, have hardly changed.How quickly ubs is able to shutter this unit will be closely watched. So will what the bank’s bosses do with their remaining investment bank. European investment banks have retreated since the financial crisis, especially in America. Both Barclays and Deutsche Bank have struggled to convince investors their businesses are worth retaining. ubs’s investment bank is profitable, but would need a mighty boost to woo billionaires with its dealmaking advice. The prospect of building an elite, capital-light bank might be appealing in theory, and was the crux of Credit Suisse’s plan to spin out its own investment bank under the moniker of “First Boston”, a famous old institution that it acquired in 1990. But in practice this would require significant turnover among ubs’s own bankers, too. Put the axe awayIt is not clear that such bloodletting is required. In time, the success of the merger will be judged by ubs’s price-to-book multiple. Morgan Stanley, which has ridden its wealth-management success to a multiple of more than two, is a worthy target. After the deal, ubs will remain a measly competitor in investment banking, but growth in the money it manages means it will close the gap in wealth management and overtake its rival in asset management. A bigger bank means bigger ambitions. ■ More

  • in

    Boeing’s Starliner losses total $1.5 billion with NASA astronauts still waiting to fly

    Boeing’s latest charge on its Starliner astronaut spacecraft brings the program’s overrun costs to $1.5 billion to date.
    The aerospace giant last month decided to indefinitely delay the first crewed Starliner launch.
    Since 2014, when NASA awarded Boeing with a nearly $5 billion fixed-price contract to develop Starliner, the company has recorded losses on the program almost every year.

    Boeing’s Starliner spacecraft is seen before docking with the International Space Station on May 20, 2022 during the uncrewed OFT-2 mission.

    Boeing on Wednesday reported a $257 million charge in the second quarter for its Starliner astronaut spacecraft program, bringing the program’s to-date overrun costs to $1.5 billion as delays continue.
    The aerospace giant blamed the charge on its decision last month to indefinitely delay the first crewed Starliner launch. Starliner was scheduled to launch in late July and carry a pair of NASA astronauts to the International Space Station.

    But Boeing discovered two new problems with Starliner and called off the launch to correct the issues. The delay was the latest in a series of disruptions in Boeing’s development of Starliner.

    Sign up here to receive weekly editions of CNBC’s Investing in Space newsletter.

    Since 2014, when NASA awarded Boeing with a nearly $5 billion fixed-price contract to develop Starliner, the company has recorded losses on the program almost every year. The charges total $1.47 billion, according to its annual reports and the company’s most recent quarterly filing.
    The annual losses have ranged from $57 million in 2018 to $489 million in 2019.

    Boeing’s program competes with Elon Musk’s SpaceX, which is poised to finish all six of its originally contracted NASA missions before Boeing flies its first.
    Still, Boeing CEO Dave Calhoun said on an earnings call Wednesday that the manufacturer is “in lockstep” with NASA on Starliner development.

    “We prioritize safety, and we’re taking whatever time is required. We’re confident in that team and committed to getting it right,” Calhoun said.
    Boeing recorded other losses in its defense, space and security unit for the second quarter: a $189 million loss in the T-7A trainer jet program and $68 million charge on its MQ-25 unit.
    Boeing last year announced additional losses on the Air Force One program, bringing charges on the contract negotiated with the Trump administration to above $1 billion. More

  • in

    GSK chief says RSV vaccine will start off slower than shingles shot – but will drive future sales

    GlaxoSmithKline CEO Emma Walmsley said she expects uptake for the company’s newly approved RSV vaccine to start off slower than it did for its blockbuster shingles shot, but she is confident that the shot will drive future sales.
    London-based GSK is preparing to roll out the vaccine in the fall, the season when the common respiratory disease typically begins to spread at higher levels.
    Walmsley’s remarks came after the company reported second-quarter revenue and earnings that topped Wall Street’s estimates. 

    Budrul Chukrut | Lightrocket | Getty Images

    GlaxoSmithKline CEO Emma Walmsley on Wednesday said she expects uptake for the company’s new RSV vaccine to start off slower than it did for its blockbuster shingles shot.
    But she is confident that the new vaccine will drive future sales. 

    related investing news

    “I think the uptake on this we need to watch for through the seasons, it won’t be the same rate of build as [the shingles vaccine] was, but we do think it’s a really key pillar and contributor,” Walmsley said during a call with reporters.
    She spoke about the respiratory syncytial virus vaccine after London-based GSK reported second-quarter earnings and revenue that topped Wall Street’s estimates. 
    Last month, GSK’s RSV shot became the first to win approval in the U.S. and European Union for the treatment of adults 60 and older. The company is preparing to roll out the vaccine this fall; the common respiratory disease typically begins to spread at higher levels in the autumn.
    RSV usually causes mild, cold-like symptoms, but it kills thousands of seniors and hundreds of children each year in the U.S. 
    The company has not provided estimates for how much revenue the RSV shot will rake in this year following its launch. But GSK’s full-year forecast expects that overall vaccine revenue will increase by a “mid-teens” percentage from last year.

    Walmsley also noted that GSK expects the vaccine to generate around 3 billion pounds, or $3.87 billion, in sales “over time.”
    GSK’s vaccine against shingles, a viral infection that causes a painful rash, is the company’s top-selling drug. The shot generated second-quarter sales of 880 million pounds, or $1.14 billion, and has been a key revenue driver since it launched in the U.S. in late 2017.
    The shot, called Shingrix, won more than 90% of the U.S. market share for shingles vaccines just five months after its launch.
    In 2018, the shot gained approval in the European Union, Japan and Canada, among other countries, and posted full-year global sales of 784 million pounds, or $1.01 billion.
    Investors are hoping that Shingrix and GSK’s RSV shot will help offset patent expirations for some of the company’s blockbuster HIV drugs in a few years. Those expirations will allow other drugmakers to launch similar and potentially cheaper versions of those medicines. More

  • in

    ‘Barbie’ box office dominance extends beyond the weekend

    On both Monday and Tuesday, Warner Bros.’ “Barbie” added $26 million in ticket sales to its domestic box office haul.
    Greta Gerwig’s bubblegum pink feature has generated $214 million during its first five days at the domestic box office.
    “Barbie” has also topped $470 million globally.

    Barbie The Movie
    Courtesy: Warner Bros. 

    It’s Barbie’s world and we’re just living in it.
    The Warner Bros. flick based on Mattel’s iconic fashion doll continued to tally record ticket sales following its historic opening weekend.

    related investing news

    On Monday, “Barbie” added $26 million to its haul, the biggest Monday in the history of Warner Bros. and the best-ever for a female director. Greta Gerwig’s bubblegum pink feature added another $26 million on Tuesday, extending its domestic box office to $214 million.
    “Barbie” exceeded opening weekend expectations, snaring $162 million over its first three days in domestic theaters. This is the highest-grossing opening for a female director in the history of cinema.
    Fewer than 100 films have topped $100 million in their opening weekend, and, traditionally, those films have been male-driven superhero fare from Marvel and DC or from marquee franchises like Harry Potter, Star Wars or Jurassic Park.
    The Margot Robbie-led film opened higher than Universal’s “The Super Mario Bros. Movie,” which snared $146.3 million during its debut and has gone on to top $1 billion worldwide during its theatrical run.
    In just five days in theaters, “Barbie” has topped $470 million globally.

    The success of “Barbie” comes at a time when studios have struggled to connect with moviegoing audiences. A series of adult-aimed blockbusters have underperformed in recent months, leading many in the industry to question if consumer tastes have shifted away from Hollywood.
    Coupled with strong results from Universal and Christopher Nolan’s “Oppenheimer,” it appears that consumers aren’t ditching theaters, they are just being more selective about what they watch. The critically acclaimed combination of “Barbenheimer” compelled audiences to see content on the biggest screens possible and in large groups.
    Movie theater chains reported record foot traffic over the weekend, noting that additional screenings for both films were added and concession sales soared.
    “Barbenheimer” will face some competition from Disney’s “Haunted Mansion” this coming weekend, but box office analysts expect word of mouth to fuel ticket sales for both “Barbie” and “Openheimer” in the weeks to come.
    Disclosure: Comcast is the parent company of NBCUniversal and CNBC. NBCUniversal distributed “The Super Mario Bros. Movie” and “Oppenheimer.” More

  • in

    The SEC wants corporate America to tell investors more about cybersecurity breaches and what’s being done to fight them

    Leon Neal | Getty Images News | Getty Images

    The Securities and Exchange Commission wants corporate America to tell investors more about cybersecurity breaches and what’s being done to fight them. Much more. 
    The SEC has voted 3-2 to adopt new rules on cybersecurity disclosure. It will require public companies to disclose “material” cybersecurity breaches within 4 days after a determination that an incident was material. 

    The SEC says it is necessary to collect the data to protect investors. Corporate America is pushing back, claiming that the short announcement period is unreasonable, and that it would require public disclosure that could harm corporations and be exploited by cybercriminals. 
    The final rules will become effective 30 days following publication of the release in the Federal Register. 
    Current cybersecurity rules are fuzzy 
    Current rules on when a company needs to report a cybersecurity event are fuzzy. Companies have to file an 8-K report to announce major events to shareholders, but the SEC believes that the reporting requirements for reporting a cybersecurity event are “inconsistent.” 
    In addition to requiring public companies to disclose cybersecurity breaches within four days, the SEC wants additional details to be disclosed, such as the timing of the incident and the material impact on the company. It will also require disclosure of management expertise on cybersecurity. 
    The pushback from corporate America sounds strikingly similar to the pushback from many of the other rulemaking proposals SEC Chair Gary Gensler has made or proposed: too much. 

    “The SEC is calling for public disclosure of considerably too much, too sensitive, highly subjective information, at premature points in time, without requisite deference to the prudential regulators of public companies or relevant cybersecurity specialist agencies,” the Securities Industry and Financial Markets Association (SIFMA), an industry trade group, said in a letter to the SEC. 
    Industry objections
    The most prominent industry concerns are: 

    Four days is too short a period. SIFMA and others claim that four days denies companies time to first focus on remediating and mitigating the impacts of any incident. 
    Premature public disclosure could harm companies. The NYSE, on behalf of its listed companies, has written to the SEC saying that corporations should be allowed to delay public disclosures in two circumstances: 1) pending remediation of the incident, and 2) if law enforcement determines that a disclosure will interfere with a civil or criminal investigation. 

    The proposed rule allows the Attorney General to delay reporting if the AG determines that immediate disclosure would pose a substantial risk to national security. 
    “Premature public disclosure of an incident without certainty that the threat has been extinguished could provide bad actors with useful information to expand an attack,” Hope Jarkowski, NYSE Group general counsel, said in the letter. 
    Nasdaq, in a separate letter to the SEC, agrees, noting that “the obligation to disclose may reveal additional information to an unauthorized intruder who may still have access to the company’s information systems at the time the disclosure is made and potentially further harm the company.” 
    Concerns about duplicate reporting 
    Another concern is overlapping regulations. Many public companies already have procedures in place to share critical information about cyber incidents with other federal agencies, including the FBI. 
    The lead agency that deals with cybersecurity is the Cybersecurity and Infrastructure Security Agency (CISA) in the Department of Homeland Security. Under legislation passed last year, CISA is adopting cybersecurity rules that require “critical infrastructure entities,” which would include financial institutions, to report cyberbreaches within three days to CISA. 
    This would conflict with the SEC’s four-day rule, and would also create duplicate reporting requirements. 
    All this goes to the central issue of who should be regulating cybersecurity. “The Commission is not a prudential cybersecurity regulator for all registrants,” SIFMA said. 
    What is the SEC trying to accomplish? 
    Cybersecurity is only a small part of the more than 50 proposed rules Gensler has out for consideration, nearly 40 of which are in the Final Rule stage. 
    If there is an underlying theme behind much of Gensler’s extensive rulemaking agenda, it is “disclosure.”  More disclosure about cybersecurity, board diversity, climate change and dozens of other issues. 
    “Gensler is claiming he wants more transparency and thinks that will protect investors,” Mahlet Makonnen, a principal at Williams & Jensen, told me. 
    “The fear the industry has is that the data collected will put unnessary burdens on industry, does not actually protect investors, and that the data can be used to grow the aggressive enforcement tactics under Gensler,” she said. 
    “The more information they have, the more the SEC can determine if there are any violations of rules and regulations. It allows them to expand enforcement actions. The SEC will say they have broad authority to protect investors, and the disclosures can be used to expand the enforcement actions.” 
    Another long-time observer of the SEC, who asked to remain anonymous, agreed that the ultimate goal of stepped up disclosure is to expand the SEC’s enforcement power. 
    “It will enable the SEC to claim they are protecting investors, and it will enable them to ask Congress for more money,” the observer told me. 
    “You don’t get more money from Congress by asking for money for market structure. You get more money by claiming you are protecting grandma.” More

  • in

    Coca-Cola says it’s done raising prices in the U.S. and Europe this year

    Coca-Cola is done hiking prices this year in developed markets like the U.S. and Europe.
    Coke’s prices were up 10% in the second quarter compared with the year-ago period.
    Customers in the U.S. and Europe are switching to private label bottled water and juices, Coke CEO James Quincey said

    A pedestrian passes a Coca-Cola delivery truck in Mexico City, Mexico, on Wednesday, Jan. 25, 2023.
    Jeoffrey Guillemard | Bloomberg | Getty Images

    For two years, Coca-Cola has been raising prices on its drinks to combat higher costs. But the company said Wednesday it’s done hiking prices this year in developed markets like the U.S. and Europe.
    Coke follows the lead of rival PepsiCo, which said in February it wouldn’t raise prices beyond its usual hike for beverages in the fourth quarter. Both companies have reported strong sales growth thanks to higher prices, but consumer demand has weakened, although not as much as expected.

    related investing news

    Coke’s prices were up 10% in the second quarter compared with the year-ago period.
    Customers in the U.S. and Europe are switching to private label bottled water and juices, Coke CEO James Quincey said Wednesday on the company’s conference call. The company reported that U.S. unit case volume fell 1% in the second quarter.
    “Across the sector, consumers are increasingly cost conscientious. They are looking for value and stocking up on items on sale,” Quincey said.
    Coke plans to keep raising prices in line with inflation in developing markets like Latin America.
    Pepsi has seen even steeper declines in demand than Coke. The Frito-Lay owner reported that its North American beverage volume tumbled 4.5% in the second quarter. Its Quaker Foods North America unit’s volume fell 5%. Frito-Lay North America was the only bright spot, reporting 1% volume growth, thanks to consumers’ enduring snack habits.
    Coke shares fell less than 1% in morning trading, despite the company raising its full-year outlook and reporting earnings and revenue that topped Wall Streeet estimates. More

  • in

    Coca-Cola raises full-year outlook as earnings beat estimates

    Coca-Cola’s second-quarter earnings and revenue topped Wall Street’s estimates.
    The beverage giant also raised its full-year outlook, following in the footsteps of rival PepsiCo.
    Coke has been been raising prices across its portfolio, including another round of hikes during the first quarter.

    Bottles of Coca Cola displayed at a grocery store on April 24, 2023 in San Rafael, California.
    Justin Sullivan | Getty Images

    Coca-Cola on Wednesday raised its full-year outlook after reporting earnings and revenue that topped estimates.
    Shares of the company rose 2% in premarket trading.

    Here’s what the company reported compared with what Wall Street was expecting, based on a survey of analysts by Refinitiv:

    Earnings per share: 78 cents adjusted vs. 72 cents expected
    Revenue: $11.97 billion adjusted vs. $11.75 billion expected

    The beverage giant reported second-quarter net income attributable to shareholders of $2.55 billion, or 59 cents per share, up from $1.91 billion, or 44 cents per share, a year earlier.
    Excluding refranchising gains, restructuring costs and other items, Coke earned 78 cents per share.
    Net sales rose 6% to $11.97 billion. The company’s organic revenue, which strips out the impact of acquisitions and divestitures, increased 11% in the quarter, fueled by higher prices.
    Following its rival PepsiCo, Coke gave a rosier outlook for the rest of the year.

    For 2023, Coke now expects comparable adjusted earnings per share growth of 5% to 6%, up from its prior forecast of a 4% to 5% rise. The company also hiked its outlook for organic revenue and now predicts an increase of 8% to 9%, up from its previous range of 7% to 8%.
    Like many food and beverage companies, Coke has been hiking prices on its products in response to higher commodity costs. In the first quarter, it raised prices again, even as PepsiCo said it wasn’t planning to increase prices this year.
    Coke’s pricing strategy hasn’t sparked significant backlash yet from customers. Worldwide, its unit case volume, which excludes the impact of pricing and currency changes, was flat for the quarter. Its U.S. volume fell just 1%, dragged down by falling demand for its namesake soda, Powerade and bottled water.
    The company’s three drinks divisions all reported flat growth for the quarter, but there were some bright spots. Coke Zero Sugar’s volume rose 5%, thanks to strong demand in North America and Latin America.
    Ultra-filtered milk brand Fairlife saw strong growth in the U.S. Coke’s coffee division also reported volume growth of 5%, fueled by Costa Coffee’s performance in the United Kingdom and China. More

  • in

    Gap taps top Mattel executive to be its new CEO

    Top Mattel executive Richard Dickson has been chosen as Gap’s next CEO, capping off a year-long search.
    The toymaker’s president and chief operating officer is credited with reviving the Barbie franchise during his tenure.

    Pedestrians walk past Old Navy and GAP stores in Times Square, New York City.
    Drew Angerer | Getty Images

    Gap announced Wednesday it’s poached a top Mattel executive to be its new CEO as the apparel giant seeks to reverse an ongoing sales slump and regain its relevancy in the fashion industry.
    Richard Dickson, the president and chief operating officer at Mattel, was chosen as Gap’s top boss after a year-long search that began last summer when former CEO Sonia Syngal left the company.

    related investing news

    2 days ago

    Since then, Gap’s chairman Bob Martin has been serving as interim CEO – a position he didn’t expect to hold as long as he had as the company struggled to find the right person for the role, he told investors during a May earnings call. 
    During his tenure with Mattel, Dickson is credited with reviving the Barbie franchise and growing the toymaker’s other top brands, including Hot Wheels and Fisher-Price, according to Mattel.
    He first joined Mattel in 2000 and most recently led its global brand portfolio, overseeing strategy, brand marketing, design and development. In the position, he also oversaw franchise management, including licensing and merchandising, live events and digital gaming.
    Dickson has also held positions at Bloomingdales and The Jones Group. The Wall Street Journal first reported his appointment to Gap. 
    Dickson joins Gap at a low-point in the retailer’s history.

    The company has been grappling with a years-long sales slump and a series of leadership shakeups across its portfolio of brands, which includes Athleta, Banana Republic, Old Navy and its namesake banner. 
    Since last fall, Gap has laid off more than 2,000 workers in an effort to streamline operations and cut costs. 
    In its most recent quarter ended April 29, sales were down 6% from the year-ago period to $3.28 billion. It reported a quarterly net loss of $18 million, improvement from a loss of $162 million in the prior year.  More